Telomir Pharmaceuticals TELO
NASDAQ TELO
$0.99 -0.03 (-2.93%)
As of: Oct 22, 2026 · 3:58 PM EDT

Telomir Pharmaceuticals (TELO) EPS (Basic) (2023 - 2026)

Updated

Telomir Pharmaceuticals' EPS (Basic) came in at -$0.79 for Q2 2026, compared with -$0.17 a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) EPS (Basic) (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Telomir Pharmaceuticals reported EPS (Basic) of -$0.92; for FY2025, it came in at -$0.33.

  • Going back by year, EPS (Basic) was -$0.56 in FY2024, -$0.48 in FY2023 and -$0.03 in FY2022.
  • The Q2 2026 figure represents the lowest quarterly EPS (Basic) in data going back to Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.95
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.09
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 2.04
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -0.54
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.68
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.62
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 4.40
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -8.44
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -0.04
10 Telomir Pharmaceuticals 60.76 Mn 40.19 Mn - -0.79
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.79
Dec 31, 2025 -0.06
Sep 30, 2025 -0.03
Jun 30, 2025 -0.17
Mar 31, 2025 -0.07
Dec 31, 2024 -0.10
Sep 30, 2024 -0.20
Jun 30, 2024 -0.05
Mar 31, 2024 -0.23
Dec 31, 2023 -0.34
Sep 30, 2023 -0.06
Jun 30, 2023 -0.06
Mar 31, 2023 -0.02
API Access

Telomir Pharmaceuticals EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=TELO&period=max&api_key=YOUR_API_KEY